EUVIMED · CrossrefZeitschrift
Oncology
ISSN 0030-2414 · S. Karger AG
Neueste Artikel
Comparison of quality of life between docetaxel and weekly paclitaxel in the neoadjuvant or adjuvant treatment of breast cancer
Practical Guide for Managing Philadelphia-Negative Myeloproliferative Neoplasms in Patients with Organ Dysfunction
Prognostic Effect of Preoperative Albumin-to-Globulin Ratio in Patients with Non-Metastatic Bladder Cancer Undergoing Radical Cystectomy
Application of a General Large Language Model-Based Classification System to Retrieve Information about Oncological Trials
Anti-Human Epidermal Growth Factor Receptor-2 Therapies in Biliary Tract Cancers: A Meta-Analysis on Disease Location, Human Epidermal Growth Factor Receptor-2 Status, and Survival Outcomes
Statin and Immune-Related Cardiovascular Events in Lung Cancer Patients Receiving Immune Checkpoint Inhibitors
Atezolizumab plus Bevacizumab Is Associated with Favorable Overall Survival over Lenvatinib in Patients with Unresectable Hepatocellular Carcinoma
Age-Stratified Risk of Carboplatin-Induced Nausea and Vomiting in Lung Cancer Patients
Analysis of Immune-Related Adverse Events of Pembrolizumab Using FAERS Database
Regorafenib Combination Therapy in Advanced Hepatocellular Carcinoma: With or without Transarterial Chemoembolization
Metastatic Patterns: Insights from Japanese Pathological Autopsy Registry Analysis
Development of an Artificial Intelligence System for Distinguishing Malignant from Benign Soft-Tissue Tumors Using Contrast-Enhanced MR Images
Lenvatinib versus Sorafenib Second-Line Therapy in Patients with Hepatocellular Carcinoma Progressed to Atezolizumab plus Bevacizumab: A Retrospective Real-World Study
The Immune Microenvironment in Prostate Cancer: A Comprehensive Review
Skin Cancer Detection in Diverse Skin Tones by Machine Learning Combining Audio and Visual Convolutional Neural Networks
Dose-Reduction of Bevacizumab in Atezolizumab plus Bevacizumab Therapy Extends Treatment duration with Disease Control in Patients with Hepatocellular Carcinoma
Clinicopathological Factors Predicting Pathological Complete Response to Neoadjuvant Anti-HER2 Therapy in HER2-Positive Breast Cancer
Development of a Patient-Centered Pathway of Care for Retinoblastoma Patients: A Mixed-Methods Pilot Study
Current Status and Future Direction of Albumin-Bilirubin in Hepatocellular Carcinoma: A Bibliometric Analysis
Simple Scoring System for Esophagogastric Varices Prediction in Hepatocellular Carcinoma Patients without Liver Stiffness Evaluation
Antibiotics May Interfere with Nivolumab Efficacy in Patients with Head and Neck Squamous Cell Carcinoma
The Combination of SHOX2 and RASSF1A DNA Methylation Had a Diagnostic Value in Pulmonary Nodules and Early Lung Cancer
Effects of Exercise during Chemo- or Radiotherapy on Immune Markers: A Systematic Review
Transarterial Chemoembolization Combined with Lenvatinib for Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
The Clinical Relevance of the Expression of SGLT2 in Lung Adenocarcinoma
Gender, Racial, and Geographical Disparities in Malignant Brain Tumor Mortality in the USA
The Glasgow Prognostic Score Predicts Outcomes of Pembrolizumab or Atezolizumab Monotherapy in Patients with Pretreated Non-Small Cell Lung Cancer
Clinical Implications of BRCA Mutations in Advanced Biliary Tract Cancer
Immune Checkpoint Inhibitor-Related Pneumonitis in Lung Cancer Patients with Interstitial Lung Disease: Significance of Radiological Pleuroparenchymal Fibroelastosis
Risk Factors of Capecitabine-Induced Hand-Foot Syndrome: A Single-Institution, Retrospective Study
Jahrgänge
2026 · 392025 · 1132024 · 1952023 · 1092022 · 932021 · 1082020 · 1372019 · 1042018 · 1242017 · 1552016 · 1192015 · 1362014 · 1232013 · 1432012 · 1142011 · 1482010 · 1532009 · 2862008 · 1122007 · 1692006 · 1372005 · 1782004 · 1502003 · 1682002 · 1572001 · 1382000 · 1291999 · 1371998 · 1051997 · 1061996 · 971995 · 951994 · 1021993 · 1151992 · 1191991 · 1041990 · 1031989 · 921988 · 1031987 · 83
EUVIMED